Pulmonary function, computerized tomography features and six-minute walk test at three months in severe COVID-19 patients treated with intravenous pulsed methylprednisolone: a preliminary report

COVID-19 ARDS has a high mortality and few therapeutic options. We present a preliminary report on our experience using high-dose pulsed methylprednisolone in COVID-19 ARDS and three-month outcomes. We performed a retrospective analysis of all patients treated with high-dose methylprednisolone for...

Full description

Bibliographic Details
Main Authors: Cristiano van Zeller, Asad Anwar, Nordita Ramos-Bascon, Natalie Barnes, Brendan Madden
Format: Article
Language:English
Published: PAGEPress Publications 2021-07-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://monaldi-archives.org/index.php/macd/article/view/1811